17 alpha-hydroxyprogesterone caproate and 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid

17 alpha-hydroxyprogesterone caproate has been researched along with 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid in 2 studies

Compound Research Comparison

Studies (17 alpha-hydroxyprogesterone caproate)	Trials (17 alpha-hydroxyprogesterone caproate)	Recent Studies (post-2010) (17 alpha-hydroxyprogesterone caproate)	Studies (15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid)	Trials (15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid)	Recent Studies (post-2010) (15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid)
517	88	251	2,577	27	327

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Deering, SH; Gotkin, JL; Hoeldtke, NJ; Howard, BC; Napolitano, PG; Paonessa, DJ; Shields, AD	1
Foglia, LM; Hill, DL; Hoeldtke, NJ; Napolitano, PG; Paonessa, DJ; Zelig, CM	1

Other Studies

2 other study(ies) available for 17 alpha-hydroxyprogesterone caproate and 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid

Article	Year
17-Hydroxyprogesterone caproate reverses induced vasoconstriction of the fetoplacental arteries by the thromboxane mimetic U46619. American journal of obstetrics and gynecology, 2006, Volume: 195, Issue:4 Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 17 alpha-Hydroxyprogesterone Caproate; Angiotensin II; Cytokines; Female; Fetus; Humans; Hydroxyprogesterones; Placenta; Pregnancy; Vasoconstriction	2006
Continuous infusion of 17-hydroxyprogesterone caproate into either the fetoplacental or intervillous circulation of a placental cotyledon attenuates vasoconstriction of the fetoplacental arteries by thromboxane mimetic U46619. American journal of obstetrics and gynecology, 2010, Volume: 202, Issue:2 Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 17 alpha-Hydroxyprogesterone Caproate; Arteries; Female; Fetus; Humans; Hydroxyprogesterones; Placenta; Pregnancy; Regional Blood Flow; Vasoconstriction	2010

Article

Year

17-Hydroxyprogesterone caproate reverses induced vasoconstriction of the fetoplacental arteries by the thromboxane mimetic U46619.

American journal of obstetrics and gynecology, 2006, Volume: 195, Issue:4

Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 17 alpha-Hydroxyprogesterone Caproate; Angiotensin II; Cytokines; Female; Fetus; Humans; Hydroxyprogesterones; Placenta; Pregnancy; Vasoconstriction

2006

Continuous infusion of 17-hydroxyprogesterone caproate into either the fetoplacental or intervillous circulation of a placental cotyledon attenuates vasoconstriction of the fetoplacental arteries by thromboxane mimetic U46619.

American journal of obstetrics and gynecology, 2010, Volume: 202, Issue:2

Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 17 alpha-Hydroxyprogesterone Caproate; Arteries; Female; Fetus; Humans; Hydroxyprogesterones; Placenta; Pregnancy; Regional Blood Flow; Vasoconstriction

2010